CTHRC1 and colon adenocarcinoma: Although the high expression of CTHRC1 and the prognostic value of COAD patients have been highlighted by previous studies, the predictive accuracy of CTHRC1 as a biomarker can vary widely in heterogeneous diseases such as COAD due to the lack of adequate sample sizes and stringent inclusion criteria.